Home » Pre-increment!Huaren Pharmaceutical: It is estimated that the net profit in the first quarter of 2022 will be 24.8267 million yuan to 28 million yuan, a year-on-year increase of 0% to 12.78% _ Oriental Fortune Net

Pre-increment!Huaren Pharmaceutical: It is estimated that the net profit in the first quarter of 2022 will be 24.8267 million yuan to 28 million yuan, a year-on-year increase of 0% to 12.78% _ Oriental Fortune Net

by admin
Pre-increment!Huaren Pharmaceutical: It is estimated that the net profit in the first quarter of 2022 will be 24.8267 million yuan to 28 million yuan, a year-on-year increase of 0% to 12.78% _ Oriental Fortune Net


  Huaren Pharmaceutical(SZ 300110, closing price: 4.36 yuan) released on the evening of April 8performanceAnnouncement, it is expected to be attributable to listed companies in the first quarter of 2022shareholderofnet profitRMB 24.8267 million to RMB 28 million, a year-on-year increase of 0% to 12.78%; the main reason for the change in performance is that during the reporting period, the company continued to strengthen the construction of core products, core teams, and core customers, further improved sales models and sales channels, and actively participated in national , provincial and prefecture-level centralized procurement, strengthen market access, implement refined investment promotion, and actively explore incremental customers while stabilizing the stock, and the sales volume and sales revenue of self-produced drugs have steadily increased. In August 2021, the company through its wholly-owned subsidiary Xi’an QujiangHuaren PharmaceuticalCo., Ltd. acquired 100% equity of Xi’an Hengjuxing Pharmaceutical Co., Ltd. and indirectly held 100% equity of Anhui Hengjuxing Pharmaceutical Co., Ltd., which will be included in the consolidated statement from August 2021. Compared with the same period of the previous year, it contributed part of the shares during the reporting period. profit.

From January to December 2021,Huaren PharmaceuticalofOperating incomeThe composition is: the pharmaceutical industry accounts for 80.53%,Pharmaceutical businessaccounting for 19.47%.

The chairman and president of Huaren Pharmaceutical are Yang Xiaodong, male, 54 years old, with a Ph.D.

(Article source: Daily Economic News)


Article source: Daily Economic News

Responsible editor: 91

See also  Video | "Chinese Chaplin" He Qichang: The Road to Magic is Endless

Original title: Pre-increment! Huaren Pharmaceutical: It is estimated that the net profit in the first quarter of 2022 will be 24.8267 million yuan to 28 million yuan, a year-on-year increase of 0% to 12.78%

Solemnly declare: Oriental Fortune.com releases this information for the purpose of disseminating more information and has nothing to do with the position of this site.

report

Share to WeChat Moments

Open WeChat,

Click “Discover” at the bottom

Use “Sweep”

You can share the webpage to the circle of friends

Scan the QR code to follow

Oriental Fortune official website WeChat

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy